Scientific Publications by FDA Staff
J Immunol 2013 Feb 1;190(3):987-96
Mouse IgM Fc receptor, FCMR, promotes B cell development and modulates antigen-driven immune responses.
Choi SC, Wang H, Tian L, Murakami Y, Shin DM, Borrego F, Morse HC 3rd, Coligan JE
FcR specific for pentameric IgM (FCMR) is expressed at high levels by B cells. Although circulating IgM has profound effects on responses to pathogens, autoimmunity, and B cell homeostasis, the biologic consequences of its binding to FCMR are poorly understood. We interrogated FCMR contributions to B cell function by studying mice that lack FCMR. FCMR transcripts are expressed at different levels by various B cell subsets. FCMR-deficient mice have reduced numbers of developing B cells, splenic follicular and peritoneal B-2 cells, but increased levels of peritoneal B-1a cells and autoantibodies. After immunization, germinal center B cell and plasma cell numbers are increased. FCMR-deficient B cells are sensitive to apoptosis induced by BCR ligation. Our studies demonstrate that FCMR is required for B cell differentiation and homeostasis, the prevention of autoreactive B cells, and responsiveness to antigenic challenge.
|Category: Journal Article|
|PubMed ID: #23267023||DOI: 10.4049/jimmunol.1202227|
|Includes FDA Authors from Scientific Area(s): Drugs|
|Entry Created: 2013-03-04||Entry Last Modified: 2015-06-03|